Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-01-03 @ 9:25 PM
Study NCT ID:
NCT03982303
Status:
UNKNOWN
Last Update Posted:
2021-10-01
First Post:
2019-06-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Hemay102 in Patients With Advanced Solid Tumors
Sponsor:
Tianjin Hemay Oncology Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HM102ST1S01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None